How does baloxavir marboxil work (mechanism of action)?
Baloxavir marboxil is a prodrug that converts in the body to its active form, baloxavir acid. The active drug inhibits the influenza virus enzyme responsible for generating viral mRNA, which the virus needs to make viral proteins.
Specifically, baloxavir acid blocks the polymerase acidic (PA) protein endonuclease activity of influenza viruses (including influenza A and B). This prevents the “cap-dependent” endonuclease cleavage step required to start viral mRNA production, which in turn reduces viral replication in infected cells.
What step of the viral life cycle does it target?
Baloxavir targets an early stage of viral RNA transcription/transcription initiation. By inhibiting the PA endonuclease, it interferes with how the virus processes host-derived capped RNA fragments so it can generate the capped viral mRNA transcripts needed for protein synthesis.
How is this different from oseltamivir (Tamiflu) or other flu antivirals?
Baloxavir’s target is different from neuraminidase inhibitors like oseltamivir. Neuraminidase inhibitors block viral release/spread by inhibiting neuraminidase. Baloxavir blocks a viral polymerase (PA endonuclease) step needed for producing viral mRNA, so it acts earlier in the replication process rather than mainly preventing release.
What are patients usually trying to achieve with it?
Because it suppresses viral replication by stopping viral mRNA production, baloxavir is used to treat acute uncomplicated influenza and to reduce the amount of virus the body has to manage. This mechanism supports clinical goal of shortening illness duration when given early, though the exact benefit depends on factors like timing of dosing, age, and disease severity.
What resistance mechanism should be aware of?
Resistance to baloxavir is associated with changes (mutations) in the influenza PA protein that reduce drug binding while preserving endonuclease function. These resistance-associated substitutions can affect how well the drug controls the infection, which is why viral genotype matters in outbreaks and treatment failures.
Sources: (none provided in your prompt)